← Open Payments lookup

ABELINA MALDONADO: Open Payments

NPI 1396212791 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$994 in 14 payments from 6 companies in 2025. Trend: 2023 $569 · 2024 $1,988 · 2025 $994

Food & beverage: $994
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$233
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$203
ABBVIE INC.4$151
Axsome Therapeutics, Inc.3$145
Neurocrine BioSciences, Inc.2$140
Teva Pharmaceuticals USA, Inc.1$122

Products named: COBENFY, CAPLYTA, VRAYLAR, Auvelity, INGREZZA, UZEDY.

Industry payments across MD — which companies pay providers there.